← Eichor
Study identifier: NCT05520034 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh

Condition: Stroke  ·  Sponsor: Hiroshima University

PhaseNA
Planned participants432
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Stroke is a major public issue that can be occurred a patient with severe and unbearable disability for a long time. Recurrence of stroke is increasing due to a lack of knowledge and compliance with treatment regarding the modifiable risk factors of stroke and behavioral and lifestyle changes. Nurse-led health education with (self) monitoring of modifiable risk factors and behaviors can be an effective way to create knowledge about the behavioral changes in stroke patients. The investigators hypothesized that health education among first stroke patients and their family caregivers could reduce the stroke recurrence rate by controlling modifiable risk factors compared to the first stroke patients without health education.

This description comes directly from the study's public registry record.

Talk to the study team

Mahabuba Afrin, PhD  ·  +8108057903018  ·  mahabuba.a32@gmail.com

Dr.Subir Chandra Das, MBBS  ·  +8801716450560  ·  drsubir12@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Institute of Neurosciences & HospitalDhaka, BangladeshRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05520034